Pacific Biosciences has appointed Christian Henry as president and CEO effective Sept. 14, 2020. Henry has served on the board of directors since 2018, including as chairman since March 2020.
John Milligan, a board member since 2013, has been appointed to succeed Henry as chairman, also effective Sept. 14.
As previously announced, Michael Hunkapiller will retire from an active operating role at the end of the year. Effective Sept. 14, Hunkapiller will assume the position of senior fellow focused on technology development until his retirement. Hunkapiller will also continue to serve on the company's board.
In addition, Pacific Biosciences has named Ben Gong as interim CFO to succeed Susan Barnes, who's retirement from the position was previously announced.